BCL2 and cancer: Lactate has been previously shown to protect cancer cells from glucose starvation via the AKT/mTORC/BCL-2 axis [52]; therefore, the increased lactate and higher stimulation capacity of AKT may play protective roles in the IR-iPSCs.